In press Recent advances in nanocarrier-based targeted drug delivery: for lung, colon, and breast cancers

Authors

  • Parisa Sabouri
  • Sogand Bahdori
  • Azam Mohsennejadesaniyani
  • Seyed Mohammad Reza Hosseini
  • Marika Sulashvili
  • Darya Nejadkourki
  • Dina Mohammadi
  • Ketevan Tavamaishvili
  • Husain AbdulSattar
  • Johan James John
  • Joen James John
  • Lili Arabuli

DOI:

https://doi.org/10.52547.jcc.5.2.3-1

Keywords:

Drug delivery Nanocarriers Lung cancer Colon cancer Breast cancer

Abstract

In recent years, the development of research and technology has provided us with different approaches which show how cancer works and how is it possible to develop different methods of treatment. Nanotechnology and nano-carriers have shown a promising approach toward the treatment of different types of cancer. Nano-carriers based targeted drug delivery have different forms such as lipid-based, polymeric-based, inorganic-based, and hybrid-based, each of them is unique in structure, size, function and ability to deliver the drugs. Therapeutic substances can be used with the help of the applied modifications to the nano-carriers. These particles have shown significant benefits such as effectiveness, safety, low toxicity, biocompatibility, biodegradability and the improved quality of the treatment. The therapeutic properties of the nano-carriers can be regulated. This can help to provide an effective treatment in a patient with a specific diagnosed disease. The treatments can be administered either orally, intravenously or by combined route. The overall results of the use of nano-carriers have certainly created an interesting approach and created an opportunity for new treatments that improve the patient’s profile.

Downloads

Published

2023-06-29

How to Cite

Sabouri , P., Bahdori, S., Mohsennejadesaniyani, A., Hosseini, S. M. R., Sulashvili , M., Nejadkourki , D., Mohammadi, D., Tavamaishvili, K., AbdulSattar, H., James John, J., James John, J., & Arabuli, L. (2023). In press Recent advances in nanocarrier-based targeted drug delivery: for lung, colon, and breast cancers. Journal of Composites and Compounds, 5(15), xx-xx. https://doi.org/10.52547.jcc.5.2.3-1

Issue

Vol. 5 No. 15 (2023)

Section

Review Articles

Categories

License

Copyright (c) 2023 The University of Georgia Publishing House (UGPH)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors will be asked, upon acceptance of an article, to transfer copyright of the article to the Publisher. This will ensure the widest possible dissemination of information under copyright laws. The submitted materials may be considered for inclusion but can not be returned.

Licensing: The JCC articles are licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source (appropriate citation), provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

*Author rights
As an author you (or your employer or institution) have certain rights to reuse your work.